Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain ... read more
Source: PubMedPublished on 2021-03-25By Joohi Jimenez-Shahed
Related Articles:
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Device profile of the Percept PC Deep Brain Stimulation system for the treatment of Parkinson's disease and related disorders March 25, 2021 Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain…
- Device profile of the Percept PC Deep Brain Stimulation system for the treatment of Parkinson's disease and related disorders March 25, 2021 Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain…
- Device profile of the Percept PC Deep Brain Stimulation system for the treatment of Parkinson's disease and related disorders March 25, 2021 Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain…
- Device profile of the Percept PC Deep Brain Stimulation system for the treatment of Parkinson's disease and related disorders March 25, 2021 Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain…
- Device profile of the Percept PC Deep Brain Stimulation system for the treatment of Parkinson's disease and related disorders March 25, 2021 Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain…
- Device profile of the Percept PC Deep Brain Stimulation system for the treatment of Parkinson's disease and related disorders March 25, 2021 Expert Rev Med Devices. 2021 Mar 25. doi: 10.1080/17434440.2021.1909471. Online ahead of print.ABSTRACTIntroduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are now available. The Percept™ PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation in DBS. Clinicians should be equipped to explain…
- Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
- 'Sunday Morning Futures' on Biden's mental capacity, Jill Biden comparing Latinos to tacos August 1, 2022 This is a rush transcript from "Sunday Morning Futures" July 17, 2022. This copy may not be in its final form and may be updated.MARIA BARTIROMO, FOX NEWS ANCHOR: Good Sunday morning, everyone. Welcome to "Sunday Morning Futures." Thanks so much for joining us. I'm Maria Bartiromo. Today: weakness on the world stage. President Biden coming home from the Middle East…
- Speech, Voice & Parkinson’s Q&A with John Dean January 28, 2021 We recently hosted a webinar with speech-language pathologist John Dean. You can get access to the recording here. We received so many questions during the session that we weren’t able to answer them all; so, John was kind enough to do some written Q&A for us. “When is a good time to start speech therapy?” It’s much better to maintain…
- The Brilliant 10: The top up-and-coming minds in science October 19, 2022 Popular Science There’s a phrase that rings loudly in the heads of Popular Science editors any time we bring together a new Brilliant 10 class: “They’ve only just begun.” Our annual list of early-career scientists and engineers is as much a celebration of what our honorees have already accomplished as it is a forecast for what they’ll do next. To…
- Monthly Research Review – October 2021 October 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
- Year in review: 2021 December 31, 2021 # # # # As with the preceding year, 2021 proved to be challenging due to the continuing COVID-19 pandemic (and it is not over yet). Vaccines were rolled out with remarkable speed, but equally new variants of the virus popped up and have kept Governments and health regulatory bodies on their toes. An amazing feature of the last two…
- 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
- Monthly Research Review – December 2020 December 31, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- Monthly Research Review – May 2021 May 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during May 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
- From wearable to invisibles December 8, 2021 # # # # New technologies that can help us to better understand and track Parkinson’s over time has been a theme here on the SoPD. Such tools could create fantastic opportunities, particularly in the context of clinical trials evaluating new therapies, by providing comparable quantitative measures. Many of these efforts have focused on wearable technologies that require user input…
- Monthly Research Review: Jaunary 2020 January 31, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2020. The post is divided into seven parts based on the type of research: Basic biology, Disease mechanism, Clinical research, New clinical trials, Clinical trial news, Other news, and…
- Monthly Research Review: January 2022 January 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…
- The Bluerockers have started July 15, 2021 # # # # On the 8th June, BlueRock Therapeutics put out a press release announcing that the first participant in their Phase I clinical trial of cell transplantation for Parkinson’s had been dosed (Click here to read the press release). The initiation of this clinical trial by the company is a major step forward for them and for the…